Wednesday, January 11, 2017

BRIEF-Redhill Biopharma announces QIDP fast-track designation granted by FDA to RHB-104 for nontuberculous mycobacteria infections

* Redhill Biopharma announces QIDP fast-track designation

granted by FDA to RHB-104 for nontuberculous mycobacteria

infections

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)